Initial Experience With a New Laparoscopic Based Robotically Assisted Surgical System for Cholecystectomy
- Conditions
- Biliary ColicCholecystitis
- Interventions
- Procedure: Laparoscopic CholecystectomyDevice: Senhance Assisted Cholecystectomy
- Registration Number
- NCT03380572
- Lead Sponsor
- Imperial College London
- Brief Summary
The Senhance™ surgical robotic system, previously known as Telelap Alf-X (TransEnterix, Morrisville, NC, USA) has recently become available in the UK. It aims to provide the robotic benefits of greater accuracy, dexterity and control with similar operational costs to traditional laparoscopy.
Patients randomly received either a standard laparoscopic cholecystectomy or the Senhance assisted cholecystectomy based on scheduled surgery date. A prospectively maintained database of the first 20 patients undergoing cholecystectomy with the Senhance Surgical System was retrospectively interrogated and compared to a concurrently treated group of 20 laparoscopically treated patients during the same timeframe.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 40
ASA I or II Confirmed diagnosis of biliary colic or cholecystitis Normal LFTs
Patients unable tor unwilling to consent BMI >40
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Laparoscopic Cholecystectomy Laparoscopic Cholecystectomy Cholecystectomy operation performed using standard laparoscopic instruments Senhance Cholecystectomy Senhance Assisted Cholecystectomy Cholecystectomy operation performed using Senhance robotic system
- Primary Outcome Measures
Name Time Method Operative Time 1 day
- Secondary Outcome Measures
Name Time Method Morbidity Data 30 days
Trial Locations
- Locations (1)
Imperial College NHS Trust
🇬🇧London, United Kingdom